Overview
Ying Liu is an Oncologist in New York, New York. Dr. Liu is highly rated in 8 conditions, according to our data. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Endometrial Cancer, and Malignant Mixed Mullerian Tumor. Dr. Liu is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
160 E 53rd St, New York, NY 10022
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 32 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
Rockefeller Outpatient Pavilion
William Tap is an Oncologist in New York, New York. Dr. Tap is highly rated in 32 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
Frequently Asked Questions about Dr. Ying Liu
How do I make an appointment with Dr. Ying Liu?
You can book an appointment with Dr. Ying Liu by calling their office at 929-390-5631. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ying Liu a top-rated expert for Ovarian Carcinosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ying Liu is classified as an Distinguished expert for Ovarian Carcinosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ying Liu specialize in?
While Dr. Ying Liu is a Oncology, they have specific expertise in Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, and Endometrial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ying Liu participate in research or clinical trials?
Yes. Dr. Ying Liu has published 2 articles and abstracts on conditions like Ovarian Carcinosarcoma. You can view a list of Dr. Ying Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ying Liu accept my insurance?
Dr. Ying Liu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 929-390-5631 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ovarian CarcinosarcomaDr. Liu isDistinguished. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Liu isDistinguished. Learn about Sertoli-Leydig Cell Tumor.
- Advanced
- Endometrial CancerDr. Liu isAdvanced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian Tumor
- Ovarian CancerDr. Liu isAdvanced. Learn about Ovarian Cancer.
- Pseudomyxoma PeritoneiDr. Liu isAdvanced. Learn about Pseudomyxoma Peritonei.
- Testicular Yolk Sac TumorDr. Liu isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Virilizing Ovarian TumorDr. Liu isAdvanced. Learn about Virilizing Ovarian Tumor.
- Experienced
- BRCA Positive Breast CancerDr. Liu isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast CancerDr. Liu isExperienced. Learn about Breast Cancer.
- Cervical CancerDr. Liu isExperienced. Learn about Cervical Cancer.
- DICER1 SyndromeDr. Liu isExperienced. Learn about DICER1 Syndrome.
- HER2 Negative Breast CancerDr. Liu isExperienced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Liu isExperienced. Learn about Inflammatory Breast Cancer.